Denali Corp - Nilai pasar DNLI

Denali Therapeutics (DNLI) relies on exclusive blood-brain barrier penetration technology, creating a significant gap between the company and its competitors. The asset value tracked on the GURU.Markets chart, which currently stands at 2.98, confirms the success of executives in attracting investment from global industry leaders. A stable top management team and partner confidence guarantee the reliable development of promising scientific research.

Denali Therapeutics Inc. - Kapitalisasi pasar DNLI (periode 04.07.2022 - 22.10.2026)

DNLI (Denali Corp): rincian analitis lan laporan miturut indikator

Ringkesan indikator lan parameter pambiji Denali Therapeutics (DNLI):

Bagan rega Denali Therapeutics Inc.|DNLI - Prakiraan gabungan firma investasi|Nilai pasar Denali Corp

Analisis fundamental perusahaan:DNLI (Denali Therapeutics Inc.)

Sampel barang denalitherapeutics.com

Market capitalization separates the fundamental value of assets from short-term price fluctuations, measuring the total volume of equity through the lens of current demand and liquidity. By analyzing the history of the company's market valuation, an investor views capitalization as the market's recognition of the uniqueness of the blood-brain barrier crossing platform, which establishes Denali Therapeutics (DNLI) as a strategic leader in the therapy of neurodegenerative diseases.

Pesaing wigati

Nilai pasar Biogen BIIB|NBIX: Kapitalisasi pasar|RGC - Nilai pasar|AXSM: Nilai pasar|ACAD: Kapitalisasi pasar|XENE - Kapitalisasi pasar|Nilai pasar Viking Therapeutics, Inc.|Kapitalisasi pasar SUPN (Supernus Pharmaceuticals, Inc.)|Kapitalisasi pasar CPRX|HRMY - Nilai pasar|Biohaven Ltd. - Biji pasar|Kapitalisasi pasar amylyx.com AMLX|TRVI - Nilai pasar|Nilai pasar PRAX (Praxis Precision Medicines Inc)|Anavex Corp (AVXL) - Nilai pasar|Nilai pasar CeriBell EEG (CBLL)|PRTA (Prothena Corporation PLC) - Kapitalisasi pasar|Kapitalisasi pasar ALEC (Alector Therapeutics)|Kapitalisasi pasar ANNX|OMER - Nilai pasar|Nilai pasar Neurogene Corp NGNE|ACIU: Kapitalisasi pasar|Voyager Therapeutics - Kapitalisasi pasar|NMRA - Kapitalisasi pasar|Scilex (SCLX) - Nilai pasar|TVGN (Tevogen Bio Holdings Inc.) - Nilai pasar|ACOG (Alpha Cognition Inc) - Kapitalisasi pasar|cogrx.com (CGTX) - Kapitalisasi pasar|Biji pasar IKT (Inhibikase Therapeutics)|SAVA (cassavasciences.com) - Nilai pasar|Assertio - Biji pasar|Nilai pasar COYA (Coya Therapeutics Inc)|VistaGen Therapeutics Inc - Kapitalisasi pasar|Nilai pasar OVID (Ovid Therapeutics Inc.)|ABOS: Kapitalisasi pasar|Nilai pasar cervomed.com (CRVO)|Nilai pasar Alterity Therapeutics Ltd.|CLNN: Nilai pasar|Kapitalisasi pasar PEPG|Kapitalisasi pasar jupiterneurosciences.com (JUNS)|Nilai pasar Relmada Therapeutics RLMD|ANVS (annovisbio.com) - Biji pasar|Grace Tx - Kapitalisasi pasar|Nilai pasar Firefly Neuroscience, Inc.|KLTO (anewmeds.com) - Biji pasar|NeuroSense Therapeutics Ltd. (NRSN) - Kapitalisasi pasar|Biji pasar RVPH|MTVA (MetaVia, Inc.) - Nilai pasar|Kapitalisasi pasar NRXS|Kapitalisasi pasar heliusmedical.com|Kapitalisasi pasar PASG (Passage Bio)|NEUP - Biji pasar|NERV - Nilai pasar|Kapitalisasi pasar athira.com ATHA|ADXN: Kapitalisasi pasar|Kapitalisasi pasar ALZN|Nilai pasar Cyclerion Therapeutics Inc.|Kapitalisasi pasar PTIX (Protagenic)|Nilai pasar Pasithea Therapeutics (KTTA)|Nilai pasar CRGT (cortigent.com)|Kapitalisasi pasar ATXI (Avenue Therapeutics, Inc.)|Kapitalisasi pasar Brainstorm Cell Therapeutics Inc. (BCLI)|CARA - Nilai pasar|CHRO (Chromocell) - Kapitalisasi pasar|ELYM: Kapitalisasi pasar|Nilai pasar Intra-Cellular Therapies, Inc. (ITCI)|Biji pasar LBPH|Kapitalisasi pasar Marinus Pharmaceuticals Inc|Nilai pasar NKGen (NKGN)|NRBO (NeuroBo Pharma) - Nilai pasar|Nilai pasar Sage Therapeutics, Inc. SAGE|synaptogen.com (SNPX) - Nilai pasar|Trevena - Kapitalisasi pasar|VIGL (Vigil Neuroscience) - Kapitalisasi pasar|WENA: Kapitalisasi pasar|Nilai pasar Cerevel Corp (CERE)